DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cefozopran
Cefozopran
Ceftaroline in the Management of Complicated Skin and Soft Tissue Infections and Community Acquired Pneumonia
Consideration of Antibacterial Medicines As Part Of
Safety and Efficacy of Ceftaroline Fosamil in the Management of Community-Acquired Bacterial Pneumonia Heather F
Ceftaroline Fosamil As an Alternative for a Severe Methicillin-Resistant Staphylococcus Aureus Infection: a Case Report
Pharmaceutical Appendix to the Tariff Schedule 2
Revision of Precautions
European Surveillance of Healthcare-Associated Infections in Intensive Care Units
抗微生物薬略語一覧表 (Abbreviations of Antimicrobial Agents) (日本化学療法学会制定)
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
E-Table 1. Drug Classification Category Name Generic Name
Directed Molecular Evolution of Fourth-Generation Cephalosporin Resistance in Wellington Moore Iowa State University
The New Fifth-Generation Cephalosporins – a Balance Between Safety and Efficacy
(12) United States Patent (10) Patent No.: US 8,383,154 B2 Bar-Shalom Et Al
Antibiotic Classes
Author Section
Revision of Precautions
Comparative Analysis of the Pathogenicity Between Multidrug-Resistant Acinetobacter Baumannii Clinical Isolates: Isolation of Highly Pathogenic Multidrug-Resistant A
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
Top View
Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition
Redalyc.Radiolytic Studies of Cefozopran Hydrochloride in the Solid State
Critically Important Antimicrobials for Human Medicine
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
6-Veterinary-Medicinal-Products-Criteria-Designation-Antimicrobials-Be-Reserved-Treatment
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
Antibiotic Resistance Gene Resource and Assay List
Cefozopran | Medchemexpress
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds S
Customs Tariff - Schedule Xxi - 1
AMR: Antimicrobial Resistance Data Analysis
Comprehensive Analysis of Antibiotic-Induced Agranulocytosis
NG198 Evidence Review G
Literature Search Strategy for Treatment of Stable
Emergence and Prevention Measures for Multidrug Resistant Pseudomonas Aeruginosa in Catheter-Associated Urinary Tract Infection in Spinal Cord Injury Patients
Animal Models in the Pharmacokinetic/Pharmacodynamic Evaluation of Antimicrobial Agents ⇑ Miao Zhao A,B, Alexander J
Therapeutic Effect of Cefozopran
Triple Combination Therapy with High-Dose Ampicillin/Sulbactam
(12) Patent Application Publication (10) Pub. No.: US 2011/0152311 A1 Dedhiya Et Al
Surveillance of Healthcare-Associated Infections and Prevention Indicators in European Intensive Care Units HAI-Net ICU Protocol, Version 2.2
Critically Important Antimicrobials for Human Medicine, 6Th Revision
Pharmaceutical Appendix to the Tariff Schedule 2
(12) United States Patent (10) Patent No.: US 8,889,826 B2 Leese Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Chromobacterium Haemolyticum Pneumonia Associated with Near-Drowning and River Water, Japan
Personalised Beta-Lactam Therapy: Basic Principles and Practical Approach Grundprinzipien Und Praxis Der Personalisierten Therapie Mit Beta-Lactamen
Critically Important Antimicrobials for Human Medicine
L:\0900\0900PHARMAPPX .Wpd
ARPEC Protocol for Drug Utilization Study
Lipopolysaccharide-Deficient Acinetobacter Baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme
N I W O 2011/152806
3 Principal Factors Affecting Choice of Antibiotic • the Identity of The
Inductive QSAR Descriptors. Distinguishing Compounds with Antibacterial Activity by Artificial Neural Networks